Workflow
Syndax Pharmaceuticals (NasdaqGS:SNDX) 2025 Conference Transcript
SyndaxSyndax(US:SNDX)2025-11-14 00:00

Syndax Pharmaceuticals (NasdaqGS:SNDX) 2025 Conference November 13, 2025 10:00 AM ET Speaker1All right, we're going to go ahead and get started. I'm Steven Willie, one of the senior biotech analysts here at Stifel, and glad to have with us for the next presentation. CEO Michael Metzger, head of R&D Nick Botwood, Syndax Pharmaceuticals. So we're going to go through a Q&A intended to be somewhat casual, so if there's any questions in the room, feel free to raise your hand. Maybe Michael, before we get started ...